Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged
In a recent study published in The Lancet Digital Health, a group of researchers analyzed severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs), focusing on the effects of medications, comorbidities, and vaccination status during different pandemic phases. Study: Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study…